Disclaimer

We’re actively expanding Guideline Genius to cover the full UKMLA content map. Therefore, you may notice some conditions not uploaded yet, or articles that currently focus on diagnosis and management for now.

We are also continuously reviewing and updating existing content to ensure accuracy and alignment with current guidelines. Some earlier articles are undergoing revision as part of this process. Once all content has been fully reviewed, this will be clearly communicated on the platform.

For updates, follow us on Instagram @guidelinegenius.

We welcome any feedback or suggestions via the anonymous feedback box at the bottom of each article and will do our best to respond promptly.

Thank you for your support.
The Guideline Genius Team

Total Live Articles: 372

Placenta Accreta Spectrum

RCOG Placenta Praevia and Placenta Accreta: Diagnosis and Management (Green-top Guideline No. 27a). Last reviewed: Sep 2018.

Definition

Placenta accreta spectrum is a condition that encompasses a range of abnormal placenta attachments, ranging from abnormally adherent tissue to deeply invasive placental tissue.

Classification and Types

Depending on the invasive depth, the placenta accreat spectrum can be divided into 3 types:

Type Definition / description
Placenta creta (least severe) Placental villi adhere to the uterine myometrium surface (without interposing the decidua)
Placenta increata Placental villi penetrate into the uterine myometrium (reaching to the serosa)
Placenta percreta (most severe) Placental villi perforate through the entire uterine wall +/- invasion of surrounding pelvic organs (most commonly the bladder)

Aetiology

The underlying cause is linked to the trauma or disruption to the integrity of the uterine endometrium and/or superficial myometrium.

Key risk factors are those that cause scarring or damage to the uterus:

  • History of placenta accreta
  • Previous Caesarean section – major contributing factor
  • Placenta praevia – major risk factor
  • Other uterine surgery / trauma (e.g. myomectomy, endometrial curettage)
  • Uterine pathologies (e.g. adenomyosis, submucousal fibroids)

Other:

  • Advanced maternal age
  • Assisted reproductive technologies

There is a high rate of placenta accreta spectrum and placenta praevia co-existence.

This is because placenta praevia strongly predisposes the development of placenta accreta spectrum. However, the reverse is not true (i.e. plaenta accreta spectrum does NOT predispose the development of placenta praevia).

Clinical Manifestation

Typical presentation:

  • Massive haemorrhage at delivery – hallmark feature
    • Often the 1st sign that a woman has placenta accreta spectrum
    • This often necessitates massive blood transfusions and can rapidly cause coagulopathy, multisystem organ failure and death
  • Failure of placenta separation at delivery with usual clinical measures
    • If the adherent placental tissue is forcefully or manually separated, it can trigger immediate and catastrophic bleeding

Placenta percreta (the most severe form) can present with features of pelvic organ invasion

  • The bladder is most commonly involved, which classically causes haematuria and storage / voiding symptoms

Antepartum haemorrhage (bleeding before delivery) is possible, but this is usually driven by the presence of a co-existing placenta praevia (common).

Isolated placenta accreta spectrum is typically asymptomatic until delivery → up to 2/3 cases remain undiagnosed until delivery

Investigation and Diagnosis

Approach (similar to placenta praevia):

  • Placenta accreta spectrum is often screened via the 18-21 week TAUS
  • If the TAUS raises suspicion of placenta accreata spectrum → TVUS

Definitive diagnosis: histopathological examination of the involved tissue after delivery

Management

Known Placenta Accreta (Antenatal Diagnosis)

The baby must be delivered in a specialist centre by an MDT

Delivery timing Planned delivery at 35 – 36+6 weeks of gestation is recommended, assuming there are no other risk factors for pre-term delivery
Mode of delivery Preferred and safest: Caesarean hysterectomy, which involves:

  • Delivery of the baby by C-section
  • Followed by hysterectomy (removal of the uterus) with the placenta left in situ

Alternative options (specialist decision, after robust risk-benefit balancing and extensive counselling):

  • In cases of mild invasions (e.g. placenta accreta) → consider uterus-preserving surgery (e.g. partial myometrial resection)
  • If a woman desires to preserve fertility → consdier expectant management (delivering the baby and leaving the placenta entirely in place)
    • Methotrexate therapy should NOT be used to try and shrink the placenta during expectant management

Attempts to manually separate the placenta from the uterine wall are STRONGLY ADVISED AGAINST, as this routinely triggers catastrophic, life-threatening haemorrhage and almost always results in a hysterectomy anyway.

Undiagnosed Placenta Accreta Spectrum (Identified At Delivery)

The following applies to placenta accreta spectrum that is identified DURING a routine C-section (where placenta accreta spectrum is NOT expected or NOT diagnosed).

Scenario Recommended management
Before delivery (i.e. the abdomen has been opened during a routine C-section and the surgeon sees the placenta accreta) Delay the surgery:

  • Do NOT deliver the baby
  • Close the abdomen
  • Urgently transfer to a specialist unit
After delivery (i.e. C-section has been done and the baby has been delivered, and the placenta unexpectedly fails to separate) Leave the placenta in situ and perform an emergency hysterectomy

Attempts to manually separate the placenta from the uterine wall are STRONGLY ADVISED AGAINST, as this routinely triggers catastrophic, life-threatening haemorrhage and almost always results in a hysterectomy anyway.

Reference

Share Your Feedback Below

UK medical guidelines made easy. From guidelines to genius in minutes!

Quick Links

Cookie Policy

Social Media

© 2026 GUIDELINE GENIUS LTD

Be first to accessour QBank

Sign up to receive major guideline updates and early access when we launch.